Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: David Lake who wrote (3891)	7/2/1998 12:03:00 PM
From: Nick	Read Replies (1) \| Respond to of 5736

And did you read the company's latest press release? TSC simply misrepresented the truth as they have done in the past and will probably continue to in the future. It a shame that TSC has to stoop this low to help ASSensio's cause! Did you also read that they cannot reach StockGenie to confirm TSC's earlier story? Wouldn't responsible journalists confirm the truth before publishing their initial reports?

To: David Lake who wrote (3891)	7/2/1998 12:13:00 PM
From: rebecca	Respond to of 5736

Mr. Lake, I disagree with your assessment of Dr Maisels reaction to ccsi's device. Though the device was approved on a VERY LARGE sample size and was statistically significant- it is the norm for follow up studies to be performed. As stated in the article, these studies can be performed and assessed very quickly .This device will not only used for screening but in subtle conditions which require medical intervention. Dr Maisels spoke openly and honestly with the hope of being involved in a device that will be used by mainstream pediatricians and nurses. Regarding the brochures, it is a well established fact that since there is no distributor to date a sales descriptive would not yet be applicable. Lastly, to all participants on this board-long and short i extend wishes for a restful and safe 4th of July. Hope the FIREWORKS will come in the near future rebecca

To: David Lake who wrote (3891)	7/2/1998 12:32:00 PM
From: David S.	Read Replies (1) \| Respond to of 5736

re: "taking orders from physicians". Tough to say whether this is true or false, but it is an interesting statement. If no manufacturing has been secured, if the LED version is not yet completed, it would be interesting to know how they are taking orders. For example, others mentioned on this thread I believe, that the company took orders in New Orleans. This statement turned out to be...(can anyone guess the answer?) What is more likely is that the company is developing a list of docs who, when pricing and delivery plans are finalized, want to be notified. I am therefore skeptical of any orders for devices. However, as I am unbiased and have an open mind, I could be wrong. Please correct me if I am wrong on this.

To: David Lake who wrote (3891)	7/3/1998 1:34:00 AM
From: Susan S.	Read Replies (2) \| Respond to of 5736

As a physician, I was surprised by Dr. Maisel's comments in the TSC article. 1. He's only received $5900 from CCSI for his work to date. Folks, unless he is the humanitarian of the decade (doing studies for CCSI in his free time), that is too little money to pay a physician to do a thorough medical research project. Most biotech and pharmaceutical companies spend millions for R & D. I wouldn't expect CCSI to be in that league, but come on, just $6000? Is there mention in the SEC filings of ANY significant R & D expenses? 2. He's NOT using the Colormate in his hospital. This speaks volumes. Why didn't he keep his Colormate and use it daily if it was so effective? Was it malfunctioning? Was it difficult to equilibrate after each use? All drugs and medical devices have a few drawbacks, even if minor. Why isn't Dr. Maisel objective enough to point out both the pros and cons? After all, his journal readers (physicians) are known to be savvy and skeptical about prescribing new products (except for Viagra!) 3. For the first time he mentions that more studies need to be done. I agree with this, but why did it take so long to bring this up? It seems that CCSI has been promising a big manufacturing deal based on the results of only two studies. Physicians are not going to rush out and order a product based on just two studies (one of which had only 43 patients), unless of course the product is truly revolutionary, which the Colormate is not. Finally, now that CCSI has stated they plan to do further multicenter studies, they will not be entering into any deals until these are completed. These kinds of studies take months to complete, even with the involvement of experienced CRO's (clinical research organizations that help companies test products). Therefore, no way can the product be rolled out at the end of summer as Darcy just stated recently. Therefore, IMO, the stock price is going to linger in the doldrums for a long time, as longs and shorts battle it out. Regards, Susan